Amalgamated Bank raised its stake in shares of Centene Co. (NYSE:CNC – Get Rating) by 1.1% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 148,239 shares of the company’s stock after purchasing an additional 1,556 shares during the period. Amalgamated Bank’s holdings in Centene were worth $12,157,000 as of its most recent SEC filing.
A number of other institutional investors also recently modified their holdings of CNC. Whittier Trust Co. of Nevada Inc. raised its holdings in Centene by 5,700.0% in the 4th quarter. Whittier Trust Co. of Nevada Inc. now owns 348 shares of the company’s stock worth $29,000 after acquiring an additional 342 shares during the period. Guardian Wealth Advisors LLC acquired a new position in shares of Centene during the 3rd quarter worth about $71,000. Covestor Ltd boosted its stake in Centene by 24.1% during the 1st quarter. Covestor Ltd now owns 856 shares of the company’s stock valued at $72,000 after purchasing an additional 166 shares during the period. EverSource Wealth Advisors LLC grew its holdings in Centene by 76.4% in the 4th quarter. EverSource Wealth Advisors LLC now owns 947 shares of the company’s stock valued at $78,000 after buying an additional 410 shares during the last quarter. Finally, U.S. Capital Wealth Advisors LLC acquired a new position in shares of Centene during the fourth quarter worth approximately $86,000. Institutional investors own 93.28% of the company’s stock.
Insider Activity at Centene
In other Centene news, Director Lori Jean Robinson sold 1,400 shares of the stock in a transaction on Thursday, April 27th. The stock was sold at an average price of $66.59, for a total value of $93,226.00. Following the transaction, the director now directly owns 8,508 shares in the company, valued at approximately $566,547.72. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. In other Centene news, CEO Sarah London bought 30,000 shares of the stock in a transaction on Friday, March 17th. The stock was purchased at an average price of $62.60 per share, with a total value of $1,878,000.00. Following the acquisition, the chief executive officer now owns 313,953 shares of the company’s stock, valued at $19,653,457.80. The purchase was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director Lori Jean Robinson sold 1,400 shares of the stock in a transaction on Thursday, April 27th. The shares were sold at an average price of $66.59, for a total value of $93,226.00. Following the completion of the transaction, the director now directly owns 8,508 shares in the company, valued at approximately $566,547.72. The disclosure for this sale can be found here. 0.33% of the stock is currently owned by company insiders.
Centene Price Performance
Centene (NYSE:CNC – Get Rating) last issued its quarterly earnings data on Tuesday, April 25th. The company reported $2.11 EPS for the quarter, missing analysts’ consensus estimates of $2.23 by ($0.12). Centene had a return on equity of 13.61% and a net margin of 1.01%. The company had revenue of $38.89 billion for the quarter, compared to the consensus estimate of $36.09 billion. During the same period in the prior year, the company earned $1.83 EPS. The firm’s revenue was up 4.6% compared to the same quarter last year. Sell-side analysts forecast that Centene Co. will post 6.44 earnings per share for the current fiscal year.
Analyst Ratings Changes
A number of equities analysts recently issued reports on CNC shares. Credit Suisse Group dropped their target price on shares of Centene from $94.00 to $87.00 in a research report on Wednesday, April 26th. The Goldman Sachs Group cut their price objective on shares of Centene from $97.00 to $74.00 and set a “neutral” rating for the company in a research report on Wednesday, February 8th. Mizuho lowered their price target on Centene from $92.00 to $80.00 and set a “neutral” rating on the stock in a research note on Tuesday, February 28th. Stephens reduced their price objective on Centene from $95.00 to $87.00 in a research report on Wednesday, April 26th. Finally, Deutsche Bank Aktiengesellschaft cut Centene from a “buy” rating to a “hold” rating and lowered their price objective for the company from $94.00 to $79.00 in a research report on Wednesday, March 8th. One research analyst has rated the stock with a sell rating, five have assigned a hold rating, twelve have issued a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, Centene presently has a consensus rating of “Moderate Buy” and an average target price of $92.00.
Centene Corp. operates as a healthcare enterprise, which engages in the provision of programs and services to government sponsored healthcare programs. It operates through the following segments: Medicaid, Medicare, Commercial, and Other. The company was founded in 1984 and is headquartered in St. Louis, MO.
- Get a free copy of the StockNews.com research report on Centene (CNC)
- Big Lots Becomes A Stomach Churning Value Play
- The Melt-Up In Marvell Is On; But Don’t Chase It Higher
- Is Apple a Growth Stock or a Value Stock?
- Costco’s Earnings Call Reassure Economists, Recession Cancelled
- Hot Inflation, What It Means For The Summer Rally
Want to see what other hedge funds are holding CNC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Centene Co. (NYSE:CNC – Get Rating).
Receive News & Ratings for Centene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centene and related companies with MarketBeat.com's FREE daily email newsletter.